Author:
Cao Xiaoyu,Guo Juan,Yang Yaran,Yu Zhibo,Pan Hua,Zhou Wei
Abstract
AbstractTo investigate the clinical characteristics of Guillain–Barré syndrome (GBS) in patients with primary Sjögren’s syndrome (SS). Records of patients with positive anti-SSA antibodies hospitalized in the Beijing Tiantan Hospital between December 2011 and May 2020 were retrieved. Patients who fulfilled the criteria for diagnosis of GBS and primary SS were included, and their clinical data were analyzed. Among the 785 patients with positive anti-SSA, 52 patients were identified in this study. They were 27 males and 25 females with median age of 59 years old. Besides anti-SSA antibodies, multiple autoantibodies were detected in these patients including antinuclear antibody, anti-Ro52, anti-mitochondrial M2, anti-thyroid peroxidase and anti-thyroglobulin autoantibodies. Preceding infection was reported in 42 patients. Hyporeflexia/areflexia and limbs weakness were the most common manifestation and 35 patients presented cranial nerve injuries. GBS disability score of 3, 4 and 5 was scaled in 28 (53.8%), 15 (28.8%) and 3 (5.8%) patients respectively. Forty-six patients received intravenous immunoglobulin (IVIG) monotherapy, 5 patients were treated by IVIG plus glucocorticoids, and 51 patients improved during hospitalization. The frequency of male gender among the patients with both GBS and primary SS suggests an independent onset of GBS and the co-existence of these autoimmune diseases in patients with multiple autoantibodies. Majority of patients with GBS and primary SS experience benign disease course.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Cafaro, G. et al. One year in review 2019: Sjögren’s syndrome. Clin. Exp. Rheumatol. 37(Suppl 118), 3–15 (2019).
2. Fisher, B. A. & Kollert, F. Equal rights in autoimmunity: Is Sjögren’s syndrome ever ‘secondary’?. Rheumatology 59, 1218–1225. https://doi.org/10.1093/rheumatology/keaa009 (2020).
3. Alunno, A. et al. The kaleidoscope of neurological manifestations in primary Sjögren’s syndrome. Clin. Exp. Rheumatol. 37(Suppl 118), 192–198 (2019).
4. Brito-Zerón, P. et al. Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren’s syndrome. Clin. Exp. Rheumatol. 31, 103–110 (2013).
5. Carvajal Alegria, G. et al. Epidemiology of neurological manifestations in Sjögren’s syndrome: Data from the French ASSESS Cohort. RMD Open 2, e000179. https://doi.org/10.1136/rmdopen-2015-000179 (2016).